New hope for advanced colon cancer: targeted drug combo tested in 150 patients
Disease control
Not yet recruiting
This study tests whether a specific combination of two drugs (irinotecan and cetuximab) works better than the current standard treatment for people with advanced colorectal cancer that has not responded to earlier therapies. About 150 adults whose cancer has certain genetic marke…
Phase: PHASE2 • Sponsor: Gruppo Oncologico Italia Meridionale • Aim: Disease control
Last updated May 06, 2026 16:15 UTC